- Belong.Life — the world’s largest digital cancer patient platform — recently announced it raised $14 million in Series B
Belong.Life — the company behind the “Belong – Beating Cancer Together” mobile app — is considered the world’s largest social network and navigator app for cancer patients, caregivers, and healthcare professionals.
Recently, Belong.Life announced it completed a $14 million Series B fundraising round led by IQVIA — which is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The Group Ventures and other existing investors also joined this round.
With this round of funding, Belong.Life is going to advance and expand the World’s Largest Cancer Social Network and the new Belong Patient Engagement Platform (PEP) — which has been gaining traction among global healthcare providers, payers, and life science companies. PEP is designed for improving patient engagement, education, compliance, satisfaction, auto-care coordination, and efficiency.
“We are honored by the support and trust of IQVIA and our investors,” said Belong.Life co-founder and chief executive officer Eliran Malki. “We at Belong are focused on building the most robust, hyper-personalized and configurable patient engagement and research platform. Starting with Belong – beating cancer together, we quickly grew to become the world’s largest social network and patient navigator app for cancer, collaborating with leading and disruptive researchers and publications in the market. Now, in addition to increasing our global cancer reach, Belong will bring its capabilities and expertise to additional diseases and stakeholders, to achieve the vision we established at the very beginning.”
Belong.Life was founded by Malki, CTO Irad Deutsch, and CFO/COO Ohad Rubin in 2015. The company is deeply personal to the founders as each of them lost relatives to cancer. And the free Belong – Beating Cancer Together patient navigation app allows cancer patients and their support network to explore and better manage their treatment journey while improving their quality of life.
“Our investment in Belong is part of our strategy to identify and accelerate disruptive technologies that can improve healthcare,” added IQVIA’s Senior Vice President of Global Technology Solutions Tal Rosenberg. “Through its unique patient engagement platform with machine learning and artificial intelligence capabilities, Belong can utilize and complement IQVIA’s solutions to transform patient engagement. We are thrilled to work with Belong as they help transition patient engagement from transactions to experiences – giving their customers the type of engagement they want.”
The Belong.Life global community gains access to a proprietary big data platform and machine learning technology that allows people to connect, receive, and share clinical information anonymously and privately discuss issues related to their condition. And the Belong Patient Engagement Platform provides healthcare organizations with an end-to-end solution that includes personalized and configurable patient engagement tools, navigation, and management services.
Belong has become the world’s largest digital cancer patient platform and the company has partnerships with leading patient advocacy associations, including the American Cancer Society, GO2 Foundation for Lung Cancer, Colorectal Cancer Canada along with many healthcare providers and pharma companies. Plus the company also conducts research, collaborates with leading universities, and has published research with The American Society of Clinical Oncology (ASCO) and several other organizations.
